ASGT is the largest medical professional organization representing researchers and scientists committed to discovering new gene therapies. The Society was established in 1996 and has grown to almost 3,000 members. ASGT is dedicated to the understanding, development and application of gene and related cell and nucleic acid therapies and the promotion of professional and public education in the field. ASGT has an official journal, Molecular Therapy, which publishes scientific meritorious papers in the areas of gene transfer, gene regulation, gene discovery, cell therapy, experimental models, correction of genetic and acquired diseases, and clinical trials. Molecular Therapy is international in scope, publishing timely reviews, commentaries, and scientific correspondence. Molecular Therapy had a 2002 impact factor of 6.275 making it essential reading for researchers and clinicians in the field of molecular and cellular therapeutics and vaccination. Molecular Therapy is published by Elsevier on a monthly basis. ASGT holds an annual meeting each year, featuring scientific symposia, workshops, oral abstract presentations, exhibits and poster sessions.